dacarbazine medac 500 mg
tzamal bio-pharma ltd - dacarbazine as citrate - powder for solution for inj/inf - dacarbazine as citrate 500 mg/vial - dacarbazine - decarbazine is indicated for the treatment of patients with metastatic malignant melanoma. further indications for dacarbazine as part of a combination chemotherapy in advanced hodgkin's disease as a second line.
dacarbazine injection, powder, lyophilized, for solution
hikma pharmaceuticals usa inc. - dacarbazine (unii: 7gr28w0fji) (dacarbazine - unii:7gr28w0fji) - dacarbazine for injection, usp is indicated in the treatment of metastatic malignant melanoma. in addition, dacarbazine is also indicated for hodgkin's disease as a second-line therapy when used in combination with other effective agents. dacarbazine is contraindicated in patients who have demonstrated a hypersensitivity to it in the past.
dacarbazine lipomed 200 mg powder for solution for injection or infusion
lipomed gmbh - dacarbazine - powder for solution for injection/infusion - 200 milligram(s) - other alkylating agents; dacarbazine
dacarbazine lipomed 500 mg powder for solution for infusion
lipomed gmbh - dacarbazine - powder for solution for infusion - 500 milligram(s) - other alkylating agents; dacarbazine
dacarbazine lipomed 1000 mg powder for solution for infusion
lipomed gmbh - dacarbazine - powder for solution for infusion - 1000 milligram(s) - other alkylating agents; dacarbazine
dacarbazine medac 500 mg, powder for solution for infusion
medac gesellschaft für klinische spezialpräparate mbh - dacarbazine - powder for solution for infusion - 500 milligram(s) - other alkylating agents; dacarbazine
dacarbazine medac 1000 mg, powder for solution for infusion
medac gesellschaft für klinische spezialpräparate mbh - dacarbazine - powder for solution for infusion - 1000 milligram(s) - other alkylating agents; dacarbazine
dacarbazine medac 200 mg, powder for solution for injection/infusion
medac gesellschaft für klinische spezialpräparate mbh - dacarbazine - powder for solution for injection/infusion - 200 milligram(s) - other alkylating agents; dacarbazine
dacarbazine medac 200 mg inj. sol. (pwdr.) i.v. vial
medac gmbh - dacarbazine citrate 270 mg - eq. dacarbazine 200 mg - powder for solution for injection - 200 mg - dacarbazine citrate 270 mg - dacarbazine
dacarbazine medac 100 mg inj. sol. (pwdr.) i.v. vial
medac gmbh - dacarbazine citrate 135 mg - eq. dacarbazine 100 mg - powder for solution for injection - 100 mg - dacarbazine citrate 135 mg - dacarbazine